These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32386930)

  • 1. Antimicrobial escalation is not beneficial for Gram-negative bacteremia in adults who remained critically ill after appropriate empirical therapy.
    Ho CY; Lee CH; Yang CY; Hsieh CC; Ko WC; Lee CC
    J Infect Chemother; 2020 Sep; 26(9):933-940. PubMed ID: 32386930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli, Klebsiella species and Proteus mirabilis bacteremia.
    Lee CC; Wang JL; Lee CH; Hung YP; Hong MY; Tang HJ; Ko WC
    Int J Antimicrob Agents; 2017 Sep; 50(3):371-376. PubMed ID: 28694235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of early empirical administration of appropriate antimicrobials on survival and defervescence in adults with community-onset bacteremia.
    Lee CC; Lee CH; Yang CY; Hsieh CC; Tang HJ; Ko WC
    Crit Care; 2019 Nov; 23(1):363. PubMed ID: 31747950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia.
    Lee CC; Lee CH; Hong MY; Tang HJ; Ko WC
    Crit Care; 2017 May; 21(1):119. PubMed ID: 28545484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Benefit of Empiric High-Dose Levofloxacin Therapy for Adults With Community-onset Enterobacteriaceae Bacteremia.
    Lee CC; Yang CY; Lee CH; Hsieh CC; Hong MY; Tang HJ; Ko WC
    Clin Ther; 2019 Oct; 41(10):1996-2007. PubMed ID: 31421908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.
    Lee CH; Hsieh CC; Hong MY; Hung YP; Ko WC; Lee CC
    Int J Antimicrob Agents; 2017 May; 49(5):617-623. PubMed ID: 28315452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia.
    Hsieh CC; Lee CH; Hong MY; Hung YP; Lee NY; Ko WC; Lee CC
    Int J Antimicrob Agents; 2016 Dec; 48(6):712-718. PubMed ID: 27836382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of inappropriate empirical antibiotic therapy in adults with community-onset gram-positive and gram-negative aerobe bacteremia.
    Yang CY; Lee CH; Hsieh CC; Hong MY; Chen MJ; Lee CC
    J Infect Chemother; 2020 Feb; 26(2):222-229. PubMed ID: 31575500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of antimicrobial strategies on clinical outcomes of adults with septic shock and community-onset Enterobacteriaceae bacteremia: de-escalation is beneficial.
    Lee CC; Lee NY; Chen PL; Hong MY; Chan TY; Chi CH; Ko WC
    Diagn Microbiol Infect Dis; 2015 Jun; 82(2):158-64. PubMed ID: 25796557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.
    Lee CC; Wang JL; Lee CH; Hsieh CC; Hung YP; Hong MY; Tang HJ; Ko WC
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical third-generation cephalosporin therapy for adults with community-onset Enterobacteriaceae bacteraemia: Impact of revised CLSI breakpoints.
    Hsieh CC; Lee CH; Li MC; Hong MY; Chi CH; Lee CC
    Int J Antimicrob Agents; 2016 Apr; 47(4):297-303. PubMed ID: 27005458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia.
    Kuo TH; Yang CY; Lee CH; Hsieh CC; Ko WC; Lee CC
    Medicine (Baltimore); 2017 Jun; 96(26):e7075. PubMed ID: 28658101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short versus long duration antimicrobial treatment for community-onset bacteraemia: A propensity score matching study.
    Lee CC; Hsieh CC; Yang CY; Hong MY; Lee CH; Tang HJ; Ko WC
    Int J Antimicrob Agents; 2019 Aug; 54(2):176-183. PubMed ID: 31108223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of Gram-negative nonfermenters on adults with community-onset bacteremia in the emergency department.
    Chiu CW; Li MC; Ko WC; Li CW; Chen PL; Chang CM; Lee NY; Lee CC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):92-100. PubMed ID: 24060496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity-matched analysis of the impact of extended-spectrum β-lactamase production on adults with community-onset Escherichia coli, Klebsiella species, and Proteus mirabilis bacteremia.
    Lee CC; Lee CH; Hong MY; Hsieh CC; Tang HJ; Ko WC
    J Microbiol Immunol Infect; 2018 Aug; 51(4):519-526. PubMed ID: 28698042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit.
    Zaragoza R; Artero A; Camarena JJ; Sancho S; González R; Nogueira JM
    Clin Microbiol Infect; 2003 May; 9(5):412-8. PubMed ID: 12848754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and impact of empirical therapy in cirrhotic adults with community-onset bacteremia.
    Hsieh CC; Lee CC; Chan TY; Hong MY; Chi CH; Ko WC
    Am J Emerg Med; 2015 Feb; 33(2):222-8. PubMed ID: 25498529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections.
    Chen HC; Lin WL; Lin CC; Hsieh WH; Hsieh CH; Wu MH; Wu JY; Lee CC
    J Antimicrob Chemother; 2013 Apr; 68(4):947-53. PubMed ID: 23264512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential impacts of inappropriate empirical therapy on ED patients with Staphylococcus aureus and streptococci bacteremia.
    Lee CH; Yang CY; Hsieh CC; Hong MY; Lee CC
    Am J Emerg Med; 2020 May; 38(5):940-946. PubMed ID: 31493980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.